• About Us
  • Privacy Policy
  • Contact
  • Home
  • Gaming
    • Consoles
      • Nintendo Switch
      • PS5
      • xbox Series X
    • PC Hardware
      • NVIDIA GeForce GTX 1650
      • AMD Ryzen
  • Technology
  • Gadget
  • Markets
  • Cryptocurrency
  • Luxury
No Result
View All Result
iZoneMedia360
No Result
View All Result

Xiaomi – Report: sales of Samsung Galaxy S21 series are lower than S20, S10 sales

Henry Romero by Henry Romero
August 5, 2021
in Xiaomi
0

Xiaomi – Report: sales of Samsung Galaxy S21 series are lower than S20, S10 sales

Related Posts

Xiaomi – Xiaomi to reveal Pad 5 series with new smartphone

Xiaomi – Ultra-high power wireless fast charging will be prohibited soon –

Xiaomi – New laptops from Redmi, LG; Realme brings magnetic charging to Android; Amazon's win in …

Xiaomi – Aluminium Profiles and Fittings Market 2195 Comprehensive Strategic Report with Parker Hannifin, Norsk Hydro, Guangdong Xingfa Aluminium, GLOBAL ALUMINIUM, Zhongwang Holdings

Korean publications citing analytical firm Kiwoom Securities report that Samsung is disappointed with the sales of the Galaxy S21 generation. The early expectations were that the series will be a hit, but that didn’t pan out.

In the first six months of availability, the S21 models have sold a total of 13.5 million units. That is 20% below what the Galaxy S20 generation managed in the same time frame and a whopping 47% less than the S10 generation.

Here’s a chart from Counterpoint Research, which shows the month-by-month sales of Galaxy S series going back to the S5:

Report: sales of Samsung Galaxy S21 series are lower than S20, S10 sales

During the first month of availability the S21 flagships sold 590,000 units on their home turf in Korea. That was the highest since the Galaxy S8, which moved 620,000 units in the first month. Global sales for the first month were slightly more than 1 million units, the 10 million mark was reached five months after the S21 series launched.

The company is reportedly betting on the Exynos 2200 – the first mobile chipset with an AMD RDNA GPU – to restore interest in the Galaxy S series flagships. This GPU is expected to be 30% faster than the current Mali GPU in the Exynos 2100 and it should beat the Adreno inside the upcoming Snapdragon 898. Of course, real world performance and whether it restores consumer interest in the series are questions for next year.

This year, with no Galaxy Note coming in the second half, Samsung will rely on the new foldables to carry the high end. And Samsung is struggling in the high end.

The company shipped 58 million smartphones in total during Q2 of this year, up from 54 million units the same quarter last year. But if S21 sales faltered, it means the increase came from entry-level and mid-range devices.

Another worry is that Xiaomi is catching up. The maker already surpassed Apple to become the second largest smartphone maker in Q2 with 53 million units sold during the second quarter.

Source 1 | Source 2 (in Korean) | Via



[Xiaomi – Report: sales of Samsung Galaxy S21 series are lower than S20, S10 sales

Tags: Xiaomi

Next Post

iPhone - How to Hide My Email on iPhone with iCloud+ and iOS 15

Popular Posts

Markets

What is the Market View on Clover Wellness Investments Corp (CLOV) Stock

by Henry Romero
August 14, 2022
0

When making investment decisions, sentiment gives a good review of what stocks financiers presently favor. Belief incorporates temporary technical analysis right into its rating as well as does not incorporate any essential evaluation such as earnings of the firm. This implies that revenues updates and also other information can considerably influence total belief. Price activity is normally the very best sign of view. For a stock to increase, financiers need to really feel good regarding it. In a similar way, a stock that is in a drop should be out of support. InvestorsObserver's View Sign considers price action and recent trends in quantity. Increasing quantities often indicate that a fad is enhancing, while decreasing volumes can signify that a reversal could come soon. The options market is one more location to obtain signals regarding sentiment. Since options enable financiers to place bets on the cost of a stock, we consider the ratio of telephone calls as well as places for stocks where options are readily available. What's Happening With CLOV Stock Today? Clover Wellness Investments Corp (CLOV) stock is trading at $3.19 since 11:11 AM on Wednesday, Aug 3, a rise of $0.09, or 2.74% (clov clover health)   from the previous closing cost of $3.10. The stock has actually traded between $3.11 and also $3.24 thus far today. Volume today is low-grade. Thus far 2,709,253 shares have actually traded contrasted to ordinary volume of 8,102,492 shares.A Lot More Concerning Clover Wellness Investments Corp. Clover Health And Wellness Investments Corp is a healthcare modern technology business. It uses its exclusive innovation system to accumulate, framework, as well as assess wellness and behavior data to improve medical results and also reduced expenses for clients. Clover Health Investments (CLOV) Scheduled to Blog Post Quarterly Revenues on Monday. Clover Health Investments (NASDAQ: CLOV - Obtain Rating) will certainly reveal its incomes outcomes after the market closes on Monday, August 8th. Analysts anticipate the business to reveal incomes of ($ 0.23) per share for the quarter. Clover Wellness Investments has actually set its FY 2022 support at EPS.Clover Health And Wellness Investments (NASDAQ: CLOV - Obtain Rating) last provided its profits outcomes on Monday, May 9th. The firm reported ($ 0.19) incomes per share (EPS) for the quarter, covering analysts' consensus quotes of ($ 0.24) by $0.05. Clover Health And Wellness Investments had a negative return on equity of 112.18% and also an unfavorable net margin of 28.64%. The firm had income of $874.38 million for the quarter, contrasted to analysts' expectations of $815.42 million. On average, experts expect Clover Health Investments to post $-1 EPS for the present fiscal year and $-1 EPS for the following . Clover Wellness Investments Price Performance. Shares of NASDAQ: CLOV opened up at $2.80 on Monday. The company has a current ratio of 1.16, a quick proportion of 1.16 and a debt-to-equity ratio of 0.04. The stock's fifty day basic relocating standard is $2.46 and its two-hundred day basic moving average is $2.71. Clover Health Investments has a 1-year low of $1.95 as well as a 1-year high of $11.13. The stock has a market cap of $1.33 billion, a PE proportion of -1.92 and a beta of 1.75. Institutional Inflows and also Discharges. Numerous large capitalists have recently added to or reduced their risks in the stock. Lead Team Inc. boosted its risk in Clover Health and wellness Investments by 0.8% in the first quarter. Lead Group Inc. currently possesses 26,087,528 shares of the business's stock worth $92,611,000 after buying an additional 200,177 shares throughout the period. BlackRock Inc. grew its risk in Clover Health and wellness Investments by 6.2% in the very first quarter. BlackRock Inc. now possesses 5,681,089 shares of the business's stock worth $20,168,000 after purchasing an extra 329,673 shares during the duration. Goldman Sachs Team Inc. expanded its stake in Clover Wellness Investments by 56.9% in the very first quarter. Goldman Sachs Group Inc. now possesses 2,199,256 shares of the firm's stock worth $7,807,000 after buying an extra 797,158 shares during the duration. State Street Corp enhanced its holdings in Clover Health Investments by 8.0% in the very first quarter. State Road Corp currently has 1,932,734 shares of the business's stock worth $6,861,000 after obtaining an extra 142,690 shares in the last quarter. Ultimately, Charles Schwab Investment Management Inc. increased its holdings in Clover Health and wellness Investments by 2.4% in the initial quarter. Charles Schwab Financial investment Monitoring Inc. currently has 1,369,743 shares of the business's stock worth $4,863,000 after obtaining an added 32,755 shares in the last quarter. Institutional capitalists possess 23.26% of the firm's stock.Clover Wellness Investments Company Profile (Obtain Rating).Clover Wellness Investments, Corp. runs as a medicare benefit insurance firm in the USA. The firm with its Clover Aide, a software application platform that gives favored service provider company and health care company health insurance for medicare-eligible consumers. It likewise focuses on non-insurance businesses.

Read more

What is the Market View on Clover Wellness Investments Corp (CLOV) Stock

The most effective deluxe SUVs 2022

Kuttymovies 2022 Tamil HD Movies Download kuttymovies.com

Bollyflix New Bollywood HD Movies Download And Install Online Free

Websites Like Snaptube

Netflix Stock has had a dreadful 2022

Load More

[mc4wp_form id="274"]


Popular Posts

Top 20 Alternate WebSites For Thepiratebay3 In 2021

by Henry Romero
April 17, 2022
0

5 Things you Required to Find Out About Z Library – The Cost-free E-book Library 2022

by Henry Romero
February 13, 2022
0

iphone 12 – This Apple MacBook Pro concept is the closest we have seen to the design expected in September 2021!

by Henry Romero
August 8, 2021
0

  • Apple
  • Technology
  • Program
  • Mobile
  • Gadget

© 2020 iZoneMedia360 - Tech & Business News

No Result
View All Result
  • Home
  • Gaming
    • Consoles
      • Nintendo Switch
      • PS5
      • xbox Series X
    • PC Hardware
      • NVIDIA GeForce GTX 1650
      • AMD Ryzen
  • Technology
  • Gadget
  • Markets
  • Cryptocurrency
  • Luxury

© 2020 iZoneMedia360 - Tech & Business News